SCHEMBL30702012

SCHEMBL30702012

Cc1cncc([N+](=O)[O-])c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 3/20 0.39
TSHR P16473 6/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR35 Q9HC97 2/20 0.37
CYP3A4 P08684 3/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HIF1A Q16665 1/20 0.36
TXNRD1 Q16881 1/20 0.36
TXNRD3 Q86VQ6 1/20 0.36
TXNRD2 Q9NNW7 1/20 0.36
CYP1A2 P05177 1/20 0.36
VCAM1 P19320 1/20 0.36
RECQL P46063 1/20 0.36
USP7 Q93009 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14494900 1.00 ALDH1A1 (0.42) ALDH1A1MAPK1LMNAHTTHSD17B10
SCHEMBL12341859 0.85 ALDH1A1 (0.49) ALDH1A1MAPK1LMNAHTTTDP1
SCHEMBL27610923 0.81 ALDH1A1 (0.32) ALDH1A1MAPK1LMNAHTTMEN1
SCHEMBL28072926 0.79 TSHR (0.50) ALDH1A1MAPK1LMNAHTTHSD17B10
SCHEMBL31093806 0.79 TSHR (0.50) ALDH1A1MAPK1LMNAHTTHSD17B10
SCHEMBL4351783 0.79 ALDH1A1 (0.49) ALDH1A1MAPK1LMNAHTTTDP1
SCHEMBL27629941 0.76 DGAT1 (0.41) ALDH1A1LMNASMN1; SMN2VCAM1MEN1
SCHEMBL1473281 0.76 TDP1 (0.56) ALDH1A1MAPK1LMNAHTTHSD17B10
SCHEMBL8159027 0.76 GPR35 (0.52) ALDH1A1MAPK1HSD17B10TDP1TSHR
SCHEMBL541960 0.76 ALDH1A1 (0.44) ALDH1A1MAPK1HSD17B10TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565574-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2025-06-11 EP disclosed
WO-2024031089-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2024-02-08 WO disclosed